Company profile

Pila Pharma

TRPV1-pathway therapeutics

PILA · Nasdaq First North Growth Market · Sweden

Public Market Listing

PILANasdaq First North Growth Market

Nasdaq First North Growth Market primary exchange listing

Live quotes, historical charts, and market capitalization for Pila Pharma are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
XEN-D0501No recent activity
Phase 2
TRPV1Small molecule
Type 2 Diabetes

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.